Showing results (351-360 of 547) with videos related to

Sort By:
Pageof 55
Plos One|August 3, 2022
Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with diseaseRichard Lieberman, Leslie K Cortes, Grace Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphomaJia Ruan, Elizabeth Hyjek, Pouneh Kermani, et al.
Medical and Pediatric Oncology|January 1, 1993
The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a reviewA W Partin, J P Gearhart, M P Leonard, et al.
Cell Cycle (Georgetown, Tex.)|May 17, 2013
Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1David Chiron, Peter Martin, Maurizio Di Liberto, et al.
Cancer|October 26, 2006
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin diseaseLale Kostakoglu, Stanley J Goldsmith, John P Leonard, et al.
Leukemia Research|May 4, 2007
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphomaGail J Roboz, John M Bennett, Morton Coleman, et al.
Leukemia & Lymphoma|December 8, 2010
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium WorkshopMichael E Williams, Joseph M Connors, Martin H Dreyling, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Measuring the burden of hundreds of BioBricks defines an evolutionary limit on constructability in synthetic biologyNoor Radde, Genevieve A Mortensen, Diya Bhat, et al.
The Journal of Urology|August 19, 2008
Reliability assessment of Society for Fetal Urology ultrasound grading system for hydronephrosisM A Keays, L A Guerra, J Mihill, et al.
Cancer|July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphomaRichard R Furman, Peter Martin, Jia Ruan, et al.
Pageof 55